000 | 01770 a2200565 4500 | ||
---|---|---|---|
005 | 20250514002405.0 | ||
264 | 0 | _c20010823 | |
008 | 200108s 0 0 eng d | ||
022 | _a1021-335X | ||
024 | 7 |
_a10.3892/or.8.4.841 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOhta, M | |
245 | 0 | 0 |
_aClinical role of Tc-99m-MIBI scintigraphy in non-Hodgkin's lymphoma. _h[electronic resource] |
260 |
_bOncology reports _c |
||
300 |
_a841-5 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnostic imaging |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
650 | 0 | 4 | _aRadiopharmaceuticals |
650 | 0 | 4 | _aTechnetium Tc 99m Sestamibi |
650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVincristine _xtherapeutic use |
700 | 1 | _aIsobe, K | |
700 | 1 | _aKuyama, J | |
700 | 1 | _aUchida, Y | |
700 | 1 | _aNakano, K | |
700 | 1 | _aGoto, S | |
700 | 1 | _aUno, T | |
700 | 1 | _aYasuda, S | |
700 | 1 | _aShigematsu, N | |
700 | 1 | _aKawata, T | |
700 | 1 | _aKitahara, H | |
700 | 1 | _aIto, H | |
773 | 0 |
_tOncology reports _gvol. 8 _gno. 4 _gp. 841-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.8.4.841 _zAvailable from publisher's website |
999 |
_c11340936 _d11340936 |